Regiospecific synthesis of 5-halo-substituted thiophene pyridyl thiourea compounds as non-nucleoside inhibitors of HIV-1 reverse transcriptase

Synthetic Communications

Volumn 34, Issue 13, 2004, Pages 2451-2461

  Venkatachalam, T K ^a   Uckun, F M ^a,b,c  

^a PARKER HUGHES INSTITUTE   (United States)

^b Drug Discovery Program   (United States)

^c Parker Hughes Clinics   (United States)

Author keywords

HIV 1; Non nucleoside inhibitors; Reverse transcriptase; Thiourea compounds

Indexed keywords

CARBONYL DERIVATIVE; HALOGEN; IMIDAZOLE DERIVATIVE; N,N DIMETHYLFORMAMIDE; PHENETHYLAMINE DERIVATIVE; PYRIDINE DERIVATIVE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; THIOPHENE DERIVATIVE; THIOUREA DERIVATIVE;

ARTICLE; CONCENTRATION RESPONSE; DRUG SYNTHESIS; ENZYME INHIBITION; HALOGENATION; POLYMERIZATION; QUANTUM YIELD; REACTION ANALYSIS; STEREOSPECIFICITY;

EID: 3543147840     PISSN: 00397911     EISSN: None     Source Type: Journal    
DOI: 10.1081/SCC-120039499     Document Type: Article

References (10)

1. Uckun, F.M.; Pendergrass, S.; Maher, D.; Zhu, D.; Tuel-Ahlgren, L.; Mao, C.; Venkatachalam, T.K. N′-[2-(2-Thiophene)ethyl]-N′-[2-(5- bromopyridyl)] thiourea as a potent inhibitor of NNI-resistant and multi-drug-reistant human immunodeficiency virus-1. Bioorg. Med. Chem. Lett. 1999, 9, 3411.
2. U.S. Patent No. 6,124,324, issued to Uckun et al., 2000.
3. Kooyman, E.C. Halo-substituted or 2,5-disubstituted thiophene compounds. Pure Appl. Chem. 1963, 7, 193.
4. March, J., Ed. Advanced Organic Chemistry; John Wiley & Sons: New York, 1992, 515.
5. Marino, G. Electrophilic substitution on five membered aromatic heterocycles. Adv. Heterocyclic Chem. 1971, 13, 235.
6. Bell, F.W.; Cantrell, A.S.; Hogberg, M.; Jaskunas, S.R.; Johansson, N.G.; Jordan, C.L.; Kinnick, M.D.; Lind, P.; Morin, J.M., Jr.; Noreen, R.; Oberg, B.; Palkowitz, J.A.; Parrish, C.A.; Pranc, P.; Sahlberg, C.; Ternansky, R.T.; Vasileff, R.T.; Vrang, L.; West, S.J.; Zhang, H.; Zhou, X.X. Phenethylthiazolylthiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogs. J. Med. Chem. 1995, 38, 4929.
7. Cantrell, A.S.; Engelhardt, P.; Hogberg, M.; Jaskunas, S.R.; Johansson, N.G.; Jordan, C.L.; Kangasmetsa, J.; Kinnick, M.D.; Lind, P.; Morin, J.M., Jr.; Muesing, M.A.; Noreen, R.; Oberg, B.; Pranc, P.; Sahlberg, C.; Ternansky, R.J.; Vasileff, R.T.; Vrang, L.; West, S.J.; Zhang, H. Phenethylthiazolylthiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and further structure-activity relationship studies of PETT analogs. J. Med. Chem. 1996, 39, 4261.
8. Vig, R.; Mao, C.; Venkatachalam, T.K.; Tuel-Ahlgren, L.; Sudbeck, E.A.; Uckun, F.M. Rational design and synthesis of phenethyl-5-bromopyridyl thiourea derivatives as potent non-nucleoside inhibitors of HIV reserve transcriptase. Bioorg. Med. Chem. 1998, 6, 1789.
9. Mao, C.; Sudbeck, E.A.; Venkatachalam, T.K.; Uckun, F.M. Rational design of N-[2-(2′,5-dimethoxyphenylethyl)]-N′-[2-(5-bromopyridyl)]- thiourea (HI-236) as a potent non-nucleoside inhibitor of drug-resistant human immunodeficiency virus. Bioorg. Med. Chem. Lett. 1999, 9, 1593.
10. Mao, C.; Sudbeck, E.A.; Venkatachalam, T.K.; Uckun, F.M. Structure-based design of non-nucleoside reverse transcriptase inhibitors of drug-resistant human immunodeficiency virus. Antivir. Chem. Chemther. 1999, 10, 233.